89 related articles for article (PubMed ID: 2915918)
1. Phospholipase C sensitive FVII activity and FVII antigen in hypertriglyceridemia.
Carvalho de Sousa J; Bruckert E; Soria C; Caen JP
Nouv Rev Fr Hematol (1978); 1989; 31(1):13-5. PubMed ID: 2915918
[TBL] [Abstract][Full Text] [Related]
2. Factor VII hyperactivity in the elderly.
Kario K; Matsuo T; Nakao K
Thromb Haemost; 1991 Jan; 65(1):25-7. PubMed ID: 2024236
[TBL] [Abstract][Full Text] [Related]
3. Effect of lipid-lowering treatment on factor VII profile in hyperlipidemic patients.
Porreca E; Di Febbo C; Amore C; Di Castelnuovo A; Baccante G; Donati MB; Cuccurullo F; Iacoviello L
Thromb Haemost; 2000 Nov; 84(5):789-93. PubMed ID: 11127857
[TBL] [Abstract][Full Text] [Related]
4. Coagulation factor VII and plasma triglycerides. Decreased catabolism as a possible mechanism of factor VII hyperactivity.
Carvalho de Sousa J; Bruckert E; Giral P; Soria C; Chapman J; Truffert J; Dairou F; De Gennes JL; Caen JP
Haemostasis; 1989; 19(3):125-30. PubMed ID: 2744628
[TBL] [Abstract][Full Text] [Related]
5. Coagulation factor VII, R353Q polymorphism, and serum choline-containing phospholipids in males at high risk for coronary heart disease.
Lindman AS; Pedersen JI; Arnesen H; Hjerkinn EM; Veierød MB; Prydz H; Seljeflot I
Thromb Res; 2004; 113(1):57-65. PubMed ID: 15081566
[TBL] [Abstract][Full Text] [Related]
6. [Plasma factor VII levels in disseminated intravascular coagulation].
Kario K; Matsuo T; Yamamoto K; Kobayashi H
Rinsho Byori; 1991 Jul; 39(7):683-8. PubMed ID: 1920859
[TBL] [Abstract][Full Text] [Related]
7. [Factor VII for a molecular marker in hypercoagulable state].
Takamiya O; Okumura N
Rinsho Byori; 1993 Jan; 41(1):83-7. PubMed ID: 8355413
[TBL] [Abstract][Full Text] [Related]
8. Low plasma levels of factor VIIc and antigen are more strongly associated with the 10 base pair promoter (-323) insertion than the glutamine 353 variant.
Humphries S; Temple A; Lane A; Green F; Cooper J; Miller G
Thromb Haemost; 1996 Apr; 75(4):567-72. PubMed ID: 8743180
[TBL] [Abstract][Full Text] [Related]
9. Plasma factor VII, triglyceride concentration and fibrin degradation products in primary hyperlipidemia: a clinical and laboratory study.
Carvalho de Sousa J; Bruckert E; Giral P; Soria C; Truffert J; Mirshahi MC; de Gennes JL; Caen JP
Haemostasis; 1989; 19(2):83-90. PubMed ID: 2731779
[TBL] [Abstract][Full Text] [Related]
10. The strong positive correlation between factor VII clotting activity using bovine thromboplastin and the activated factor VII level.
Kario K; Matsuo T; Asada R; Sakata T; Kato H; Miyata T
Thromb Haemost; 1995 Mar; 73(3):429-34. PubMed ID: 7667824
[TBL] [Abstract][Full Text] [Related]
11. Association of coagulation factor VII with the risk of myocardial infarction in the Chinese.
Cai Q; Chen J; Ma H; Song J; Xu M
Chin Med J (Engl); 2000 Dec; 113(12):1059-63. PubMed ID: 11776135
[TBL] [Abstract][Full Text] [Related]
12. Serum phospholipids are the main environmental determinants of activated factor VII in the most common FVII genotype. European Union Concerted Action "Clotart".
Mariani G; Bernardi F; Bertina R; Vicente VV; Prydz H; Samama M; Sandset PM; Di Nucci GD; Testa MG; Bendz B; Chiarotti F; Ciarla MV; Strom R
Haematologica; 1999 Jul; 84(7):620-6. PubMed ID: 10406904
[TBL] [Abstract][Full Text] [Related]
13. Triglyceride dependence of factor VII coagulant activity in deep venous thrombosis.
Mukherjee M; Dawson G; Sembhi K; Kakkar VV
Thromb Haemost; 1996 Oct; 76(4):500-1. PubMed ID: 8902984
[TBL] [Abstract][Full Text] [Related]
14. Levels of factor VIIc associated with decreased tissue factor pathway inhibitor and increased plasminogen activator inhibitor-1 in dyslipidemias.
Zitoun D; Bara L; Basdevant A; Samama MM
Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):77-81. PubMed ID: 8548430
[TBL] [Abstract][Full Text] [Related]
15. Factor VII hyperactivity in acute myocardial thrombosis. A relation to the coagulation activation.
Carvalho de Sousa J; Azevedo J; Soria C; Barros F; Ribeiro C; Parreira F; Caen JP
Thromb Res; 1988 Jul; 51(2):165-73. PubMed ID: 3187958
[TBL] [Abstract][Full Text] [Related]
16. Detection of circulating tissue factor and factor VII in a normal population.
Albrecht S; Kotzsch M; Siegert G; Luther T; Grossmann H; Grosser M; Müller M
Thromb Haemost; 1996 May; 75(5):772-7. PubMed ID: 8725722
[TBL] [Abstract][Full Text] [Related]
17. Analysis of biological phenotypes from 42 patients with inherited factor VII deficiency: can biological tests predict the bleeding risk?
Giansily-Blaizot M; Verdier R; Biron-Adréani C; Schved JF; Bertrand MA; Borg JY; Le Cam-Duchez V; Briquel ME; Chambost H; Pouymayou K; Dutrillaux F; Favier R; Martin-Toutain I; Verdy E; Gay V; Goudemand J; Navarro R; Durin A; d'Oiron R; Lambert T; Pernod G; Barrot C; Peynet J; Bastenaire B; Sie P; Stieltjes N; Torchet MF; de Moerloose P;
Haematologica; 2004 Jun; 89(6):704-9. PubMed ID: 15194538
[TBL] [Abstract][Full Text] [Related]
18. Non-fasting factor VII coagulant activity (FVII:C) increased by high-fat diet.
Bladbjerg EM; Marckmann P; Sandström B; Jespersen J
Thromb Haemost; 1994 Jun; 71(6):755-8. PubMed ID: 7974344
[TBL] [Abstract][Full Text] [Related]
19. Population correlates of coagulation factor VII. Importance of age, sex, and menopausal status as determinants of activated factor VII.
Scarabin PY; Vissac AM; Kirzin JM; Bourgeat P; Amiral J; Agher R; Guize L
Arterioscler Thromb Vasc Biol; 1996 Sep; 16(9):1170-6. PubMed ID: 8792771
[TBL] [Abstract][Full Text] [Related]
20. Postprandial activation of coagulant factor VII by long-chain dietary fatty acids.
Sanders TA; Miller GJ; de Grass T; Yahia N
Thromb Haemost; 1996 Sep; 76(3):369-71. PubMed ID: 8883272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
